Mizuho raised the firm’s price target on Guardant Health (GH) to $135 from $120 and keeps an Outperform rating on the shares. The firm updated models in the medical devices and diagnostics group.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GH:
- Guardant Health price target raised to $130 from $100 at TD Cowen
- RBLX, META, GH, IONS: Cathie Wood Loads Up on Roblox, Trims Meta and Biotech Stocks
- Guardant Health management to meet virtually with BTIG
- TEM, KDK, PSNL: Cathie Wood Loads Up on AI Health Tech, Trims SHOP & ROKU
- Guardant Health price target raised to $115 from $85 at Guggenheim